PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named Mike Nuckols as one of the 2019 PM360 ELITE 100. Now in its fifth year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today. Mike is one of only three Creative Directors named among the ELITE 100.
Marc Iskowitz and Larry Dobrow interview Tom Dudnyk about why he started his own agency and discuss the Transforming Healthcare conference panel about the future of value-based reimbursement.
The biggest story that is not being told is that HealthTech companies are transforming themselves in ways that more closely resemble wholesale reinvention. From product development, to sales and organizational models, more internally focused disruption is taking place than ever before.
Healthcare providers have resisted the call to lead the value-based care movement. In 2019, the energy they are expending to resist change gets replaced by the energy to lead it. Why? They realize that the medical disciplines and business models that support them are no longer financially viable. The result?
To predict how 2019 could unfold, MD+DI looked back over 2018’s progress. MD+DI checked in with a few healthcare and medtech experts for their perspectives.
PM360 asked 12 experts in the field to look forward and imagine, based on current trends, what marketers and marketing will look like in five to 10 years.
With technology moving at breakneck speed and payers continuing to push value-based care, here are a few thoughts on what medtech should expect next year.
